papillary thyroid carcinoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Unknown (1)

Interventional (2)

Hôpital le Vinatier (1)
Memorial Sloan Kettering Cancer Center (1)

No (2)

No (2)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadcancer

I am/have/hadBRAF

I am/have/hadthyroid cancer

I am/have/hadmeasurable disease

I am/have/hadthyroid carcinoma

I am/have/hadmetastasis

I am/have/hadgilbert's syndrome

I am/have/hadabsolute neutrophil count

I am/have/hadexternal beam radiation therapy

I am/have/hadplatelet count

I am/have/hadfollicular thyroid cancer

I am/have/hadlipase

I am/have/hadcoagulation therapy

I am/have/hadbraf v600e

I am/have/hadthyroid cancer, follicular

I am/have/hadpet/ct

I am/have/hadprimary tumor

I am/have/hadmalabsorption syndrome

I am/have/hadbraf v600e mutation positive

I am/have/hadanticoagulation therapy

added new label for I am/have/had

more

I am looking for

I am looking fortotal bilirubin

I am looking foravid

I am looking forvemurafenib

I am looking forlipase

I am looking forcopanlisib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 251 clinical trials

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

The purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when given …

thyroid cancer

measurable disease

BRAF

braf v600 mutation

platelet count

0 views
19 Feb, 2024
7 locations

21
22
23
24
25
26

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.